Tarbox Family Office, Inc. Corcept Therapeutics Inc Transaction History

Tarbox Family Office, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$17.33 - $25.3 $1,525 - $2,226	-88 Closed	0 $0
Q2 2021 Jul 16, 2021	SELL	$19.97 - $24.43 $499 - $610	-25 Reduced 22.12%	88 $2,000
Q3 2020 Oct 22, 2020	BUY	$12.46 - $19.98 $311 - $499	25 Added 28.41%	113 $2,000
Q2 2020 Jul 23, 2020	BUY	$11.0 - $18.26 $968 - $1,606	88 New	88 $1,000

319

88.1M

1.07M

822K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.